HEXA and lysosomal storage disease: This work describes a system consisting of the recombinant HexA enzyme immobilized on polylactic acid (PLA) nanoparticles (NPs), using a procedure that we have previously developed and patented, for the development of a drug-delivery system in the treatment of Sandhoff Lysosomal Storage Disease.